Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$600.8K
83.33K shares
What this filing means
HECHT BETH plans to sell 83.33K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $600.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006741
Officer· See Remarks
Since Oct 2021
83.33K
Shares to sell
$600.8K
Approx. market value
50K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Restricted Stock Units
N/A
1/31/2023
37.41KEmployee Stock Purchase Plan
Cash
6/30/2020
10.03KOpen Market Purchase
Cash
3/13/2020
2.56KTotal acquired50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2023 | Restricted Stock Units N/A | 37.41K | — |
6/30/2020 | Employee Stock Purchase Plan Cash | 10.03K | — |
3/13/2020 | Open Market Purchase Cash | 2.56K | — |
| Total | 50K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
16.67K
Market value
$101.0K
6/1/2026
—Completed
Units to sell
16.67K
Market value
$103.8K
5/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
50K
Market value
$396.0K
7/1/2026
Total
Units
83.33K
Value
$600.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 16.67K | $101.0K | — | Completed |
5/1/2026 | 16.67K | $103.8K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 50K | $396.0K | NASDAQ | Planned |
| Total | 83.33K | $600.8K | ||